What does GELBOPHARMA do?

GELBOPHARMA is a wholesaler in Wavre. Private Limited, started on 15 December 2004, 2 establishments.

What is the address of GELBOPHARMA?

The registered office of GELBOPHARMA is located at Avenue Edison 19 box D, 1300 Wavre.

Is GELBOPHARMA still active?

Yes. According to the CBE (31 October 2026) GELBOPHARMA is active, legal situation “Normale toestand”, started on 15 December 2004.

Is GELBOPHARMA registered on Peppol?

Yes, GELBOPHARMA is registered on the Peppol network with ID 0208:0870583413.

What is the enterprise number of GELBOPHARMA?

The enterprise number of GELBOPHARMA is BE0870583413.

When was GELBOPHARMA founded?

GELBOPHARMA was founded on 15 December 2004.

Who are the directors of GELBOPHARMA?

According to the 2025 annual accounts, the directors of GELBOPHARMA are: REGINE BOSMAN, GUIDO GELOEN.

Is GELBOPHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 December 2004; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did GELBOPHARMA make in 2025?

GELBOPHARMA posted a profit after taxes of € 5,574 in financial year 2025.

What is the revenue of GELBOPHARMA?

In its most recent annual accounts (2025), GELBOPHARMA reported revenue of € 742,519.

Does GELBOPHARMA have a website?

Yes, GELBOPHARMA has a website at gelbopharma.com.

GELBOPHARMA (Private Limited) - Wavre - BE0870583413

Dossier GELBOPHARMA, printed on 1 November 2026 from databakkes.be/en/0870583413/gelbopharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

GELBOPHARMA from Wavre, company number BE0870583413, closed financial year 2025 with a result of € 5,574 after tax. For that financial year GELBOPHARMA recorded revenue of € 742,519 and equity of € 172,950. Compared with financial year 2024, the result moved from € -50,149 to € 5,574. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 25, 2026.

What it is worth Growing

€ 172,950

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 5,574

▲ still € 50,149 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 17,550

▼ 3% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 140,350.

People and assets in 2025

Wage cost

€ 22,373

▼ 36% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 7,115

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 6,099

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 63,410

▼ 16% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 11,671

▼ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 812,367 Revenue 2022: € 812,367 First fiscal year in the series	€ 750,849 Revenue 2023: € 750,849 ▼ 8% vs 2022 (€ 812,367) Unfavourable step	€ 748,986 Revenue 2024: € 748,986 Unchanged (€ 750,849) Unfavourable step	€ 742,519 Revenue 2025: € 742,519 ▼ 1% vs 2024 (€ 748,986) Unfavourable step	▼ 1%
Gross margin	€ 227,010 Gross margin 2022: € 227,010 First fiscal year in the series	€ 10,990 Gross margin 2023: € 10,990 ▼ 95% vs 2022 (€ 227,010) Unfavourable step	€ 30,748 Gross margin 2024: € 30,748 ▲ 180% vs 2023 (€ 10,990) Favourable step	€ 42,124 Gross margin 2025: € 42,124 ▲ 37% vs 2024 (€ 30,748) Favourable step	▲ 37%
Profit after taxes	€ 117,585 Profit after taxes 2022: € 117,585 First fiscal year in the series	€ 139,573 Profit after taxes 2023: € 139,573 ▲ 19% vs 2022 (€ 117,585) Favourable step	€ -50,149 Profit after taxes 2024: € -50,149 ▼ € 189,721 vs 2023 (€ 139,573) Unfavourable step	€ 5,574 Profit after taxes 2025: € 5,574 ▲ € 55,723 vs 2024 (€ -50,149) Favourable step	▲ € 55,723
Equity	€ 279,384 Equity 2022: € 279,384 First fiscal year in the series	€ 217,524 Equity 2023: € 217,524 ▼ 22% vs 2022 (€ 279,384) Unfavourable step	€ 167,376 Equity 2024: € 167,376 ▼ 23% vs 2023 (€ 217,524) Unfavourable step	€ 172,950 Equity 2025: € 172,950 ▲ 3% vs 2024 (€ 167,376) Favourable step	▲ 3%
Total debts	€ 175,312 Total debts 2022: € 175,312 First fiscal year in the series	€ 213,552 Total debts 2023: € 213,552 ▲ 22% vs 2022 (€ 175,312) Unfavourable step	€ 98,019 Total debts 2024: € 98,019 ▼ 54% vs 2023 (€ 213,552) Favourable step	€ 83,393 Total debts 2025: € 83,393 ▼ 15% vs 2024 (€ 98,019) Favourable step	▼ 15%
Cash	€ 28,027 Cash 2022: € 28,027 First fiscal year in the series	€ 36,147 Cash 2023: € 36,147 ▲ 29% vs 2022 (€ 28,027) Favourable step	€ 18,157 Cash 2024: € 18,157 ▼ 50% vs 2023 (€ 36,147) Unfavourable step	€ 17,550 Cash 2025: € 17,550 ▼ 3% vs 2024 (€ 18,157) Unfavourable step	▼ 3%
Retained profit	€ 246,784 Retained profit 2022: € 246,784 First fiscal year in the series	€ 184,924 Retained profit 2023: € 184,924 ▼ 25% vs 2022 (€ 246,784) Unfavourable step	€ 134,776 Retained profit 2024: € 134,776 ▼ 27% vs 2023 (€ 184,924) Unfavourable step	€ 140,350 Retained profit 2025: € 140,350 ▲ 4% vs 2024 (€ 134,776) Favourable step	▲ 4%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 60,000 Dividend 2023: € 60,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 60,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 31,188 Bank debt 2022: € 31,188 First fiscal year in the series	€ 30,993 Bank debt 2023: € 30,993 ▼ 1% vs 2022 (€ 31,188) Favourable step	€ 6,082 Bank debt 2024: € 6,082 ▼ 80% vs 2023 (€ 30,993) Favourable step	€ 6,099 Bank debt 2025: € 6,099 Unchanged (€ 6,082) Unfavourable step
Balance sheet total	€ 490,054 Balance sheet total 2022: € 490,054 First fiscal year in the series	€ 431,077 Balance sheet total 2023: € 431,077 ▼ 12% vs 2022 (€ 490,054) Unchanged	€ 265,394 Balance sheet total 2024: € 265,394 ▼ 38% vs 2023 (€ 431,077) Unchanged	€ 256,342 Balance sheet total 2025: € 256,342 ▼ 3% vs 2024 (€ 265,394) Unchanged	▼ 3%

Key figures of GELBOPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GELBOPHARMA?

What happened at GELBOPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 25, 2026 New annual accounts for financial year 2025: profit of € 5,574. filed late Source: NBB ↗
Apr 7, 2014 New establishment in Perwez. KBO
Dec 15, 2004 New establishment in Wavre. KBO
Dec 15, 2004 Start of the company according to the CBE. KBO

In short

From € 117,585 profit in 2022 to € 5,574 profit in 2025.

Paid € 31,682 in corporate taxes since 2022.

Best year ever: 2023, with € 139,573 profit.

Paid out € 60,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

REGINE BOSMAN GUIDO GELOEN

GELBOPHARMA

Behind GELBOPHARMA are REGINE BOSMAN and GUIDO GELOEN.

Directors

According to the 2025 annual accounts

REGINE BOSMAN

Director

GUIDO GELOEN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Edison 19 box D

1300 Wavre

2.229.151.159

Riège du Bois Chapelain 11

1360 Perwez

Active since 7 April 2014

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

RMT&CO

€ 741,271 gross margin · 2026

M&M PROJECTS

€ 57,482 gross margin · 2025

ALLONA BELGIUM

€ 754,820 gross margin · 2026

LIMACO

€ 35,868 gross margin · 2024

The Halo Group

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS gelbopharma.com

Technologies

AMPAWS S3ApacheFont AwesomeGoogle AnalyticsGoogle FontsLightboxOpenCartOptinMonsterPHPWP RocketWooCommerceWordPressYoast SEOjQueryjsDelivrlazysizes

Hosting & Email

Email provider

Self-hosted

Hosting

INFOMANIAK-AS, CH

Domain

gelbopharma.com

Registered

2004-11-07

Registrar

Infomaniak Network SA

Expires

2026-11-07

Website info

HTTPS Ja

Languages FR

Features

Webshop Blog Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0870.583.413

VAT number

BE 0870.583.413

Registered office

Avenue Edison 19 bus D, 1300 Wavre

Names & denominations

GELBOPHARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

15 December 2004

Peppol

Active · Active since 30 Jun 2025

Contact

gelbopharma.com [email protected] +3210867577

Activities · NACE

Groothandel in andere voedingsmiddelen, neg

Overige gespecialiseerde groothandel in voedingswaren

Groothandel in groenten en fruit, muv consumptieaardappelen

Activiteiten van kuuroorden, sauna’s en stoombaden

Sauna's, solaria, baden enz.

View on CBE Public ↗ Annual accounts (NBB) ↗

GELBOPHARMA

Financials

What happened to GELBOPHARMA?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Network

Details

Frequently asked questions